PLYX · Polaryx Therapeutics, Inc. · Documents
$2.01
+0.01 (+0.50%)
At close · Oct 12
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These matters, along with the conditions described above, raise substantial doubt about the Company's ability to continue as a going concern for a period of twelve months from the date these financial statements were available to be issued.”View the 10-Q filed Aug 13, 2026
Market Cap
$99.69M
Shares
49.85M
Volume · Oct 12
16.41K
Avg daily vol (3M)
75.64K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-09-14 | 2026-09-10 | |
| 8-K | 2026-09-01 | — | |
| 10-Q | 2026-08-13 | 2026-06-30 | |
| DEF 14A | 2026-07-28 | 2026-09-10 | |
| 8-K | 2026-07-21 | 2026-07-19 | |
| 8-K | 2026-07-17 | 2026-07-16 | |
| 8-K | 2026-05-28 | 2026-05-27 | |
| 10-Q | 2026-05-15 | 2026-03-31 | |
| Investor Event Transcript | 2026-04-16 | 2026-06-30 | |
| 10-K | 2026-03-24 | 2025-12-31 |
Showing 1–10 of 10 filings